...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Knowledge-based analysis of multi-potent G-protein coupled receptors ligands.
【24h】

Knowledge-based analysis of multi-potent G-protein coupled receptors ligands.

机译:基于知识的多效G蛋白偶联受体配体分析。

获取原文
获取原文并翻译 | 示例
           

摘要

A large number of chemical structures that interact with G-protein coupled receptors (GPCRs) have been disclosed in patents or published papers. Most of these compounds are selective for a given protein target; however, it is well recognized that some GPCR-drugs interact with multiple targets. Using a literature database, we have identified compounds that act on different GPCRs. These protein targets are usually divided in three main classes, A, B and C, based on sequence similarity, but they can also be grouped pharmacologically based on endogenous ligand characteristics. In this paper, we specifically focus on compounds able to recognize two different classes or different pharmacological clusters within the same class. Despite the large number of GPCR ligands described in the literature, we identified a limited number of molecules acting on both classes A and B, only few acting on classes A and C and none acting on class B and C receptors. A search for bi- or multi-potent compounds exhibiting activities on different pharmacological clusters of class A receptors revealed cases of cross reactivity, the most frequent concerning amine and peptide receptor clusters.
机译:与G蛋白偶联受体(GPCR)相互作用的许多化学结构已在专利或已发表的论文中公开。这些化合物中的大多数对给定的蛋白质靶标具有选择性。但是,众所周知,某些GPCR药物可与多个靶标相互作用。使用文献数据库,我们确定了可在不同GPCR上起作用的化合物。根据序列相似性,这些蛋白质靶标通常分为三大类,即A,B和C,但也可以根据内源性配体特性在药理上进行分组。在本文中,我们特别关注能够识别两个不同类别或同一类别中不同药理学簇的化合物。尽管文献中描述了大量的GPCR配体,但我们确定了同时作用于A类和B类的分子数量有限,仅作用于A类和C类的分子很少,没有作用于B类和C类受体的分子。搜寻对A类受体的不同药理簇具有活性的双效或多效化合物,发现了交叉反应的情况,其中最常见的是胺和肽受体簇。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号